For Healthcare Professionals

Pemigatinib in Treating Patients With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Rearrangement


About the study

This is a phase 2 study to investigate the efficacy and safety of Pemigatinib in treating patients with advanced/metastatic or surgically unresectable cholangiocarcinoma with FGFR2 rearrangement who have failed at least 1 previous therapy

Who can take part

You may be eligible to participate in the study if you meet the following criteria:


Inclusion Criteria:

  1. Men and women, aged 18 or older.
  2. Histologically or cytologically confirmed cholangiocarcinoma which was considered to be advanced/metastatic or surgically unresectable by the investigator through image examination.
  3. Radiographically measurable disease per RECIST v 1.1
  4. Documentation of FGFR2 rearrangement.
  5. Documented disease progression after at least 1 line of prior systemic therapy.
  6. ECOG performance status of 0~1.
  7. Life expectancy ≥12 weeks.


Exclusion Criteria:

  1. Prior receipt of a selective FGFR inhibitor.
  2. History of calcium and phosphate hemostasis disorder or systemic mineral imbalance with ectopic calcification of softy tissues ( exception: skin, kidney, tendons or vessels due to injury, disease, and aging, in the absence of systemic mineral imbalance).
  3. Currently evidence of clinically significant corneal or retinal disorder confirmed by ophthalmologic examination.
  4. Use of any potent CYP3A4 inhibitors or inducers within 14 days or 5 half-lives, whichever is shorter, before the first dose of study drug. Topical ketoconazole will be allowed.

pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply

Contact the study center to learn if this study is a good match for you.

Study’s details



Age (in years)



Phase 2

Participants needed


Est. Completion Date

Dec 30, 2023

Treatment type



Innovent Biologics (Suzhou) Co. Ltd. identifier


Study number


Understanding Clinical Trials

Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?


Sign up to save your favorites, 
receive newsletters, resources, and alerts 
about clinical trials related to your conditions of interest.